The electroencephalographic sleep pattern in schizophrenic patients treated with clozapine or classical antipsychotic drugs.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Psychiatric Research

• Publication date

  1996-11-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0022-3956(96)00022-2PMID 9023785
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The influence of ipsapirone, a 5-HT1A agonist, on sleep patterns of healthy subjects

  2005cited by this paper
• Biochemical and behavioural properties of clozapine

  2004cited by this paper
• Clozapine, negative symptoms, and extrapyramidal side effects.

  1994cited by this paper
• D1-, D2-, and 5-HT2-receptor occupancy in clozapine-treated patients.

  1994cited by this paper
• An overview of the mechanism of action of clozapine.

  1994cited by this paper
• Periodic leg movements (PLM): their relationship to sleep stages.

  1993cited by this paper
• PET Analysis Indicates Atypical Central Dopamine Receptor Occupancy in Clozapine-Treated Patients

  1992cited by this paper
• Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

  1991cited by this paper
• Effect of neuroleptic treatment on polysomnographic measures in schizophrenia.

  1991cited by this paper
• From early to late adulthood. Changes in EEG sleep of depressed patients and healthy volunteers.

  1991cited by this paper
• Clozapine. A novel antipsychotic agent.

  1991cited by this paper
• Negative Schizophrenic Symptoms: Pathophysiology and Clinical Implications

  1991cited by this paper
• Sleep EEG changes in schizophrenia during haloperidol treatment

  1989cited by this paper
• Modulation of rapid eye movement sleep in humans by drugs that modify monoaminergic and purinergic transmission.

  1989cited by this paper
• Clozapine: guidelines for clinical management.

  1989cited by this paper
• Effects of seganserin, a 5-HT2 antagonist, and temazepam on human sleep stages and EEG power spectra.

  1989cited by this paper
• Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

  1988cited by this paper
• Anatomically Selective Action of Atypical Neuroleptics on the Mesocorticolimbic Dopamine System

  1988cited by this paper
• 5-HT2 receptors could be primarily involved in the regulation of slow-wave sleep in the rat.

  1987cited by this paper
• 5-Hydroxytryptamine-2 antagonist increases human slow wave sleep.

  1986cited by this paper
• Sleep: Neurotransmitters and Neuromodulators

  1985cited by this paper
• Neurobiology of mood disorders

  1984cited by this paper
• Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro.

  1984cited by this paper
• Sleep mechanisms: biology and control of REM sleep.

  1982cited by this paper
• Biphasic effects of pimozide on sleep-wakefulness in dogs.

  1980cited by this paper
• A psychophysiological investigation of the long-term effects of clozapine upon sleep patterns of normal young adults

  1978cited by this paper
• Effects of prolonged administration of pimozide on sleep-EEG patterns in psychiatric patients.

  1977cited by this paper
• A psychophysiological investigation of the short-term effects of clozapine upon sleep parameters of normal young adults.

  1977cited by this paper
• Effect of prolonged chlorpromazine administration on the sleep of chronic schizophrenics.

  1974cited by this paper
• Marked Increase in REM Sleep Produced by a New Antipsychotic Compound*

  1973cited by this paper
• REM inhibitory effect of L-DOPA infusion during human sleep.

  1973cited by this paper
• A manual of standardized terminology, technique and scoring system for sleep stages of human subjects

  1968cited by this paper

• REM sleep in schizophrenia: a systematic review and meta-analysis.

  2025cites this paper
• Clozapine and objective assessment of hypersomnolence in patients with schizophrenia: a systematic review

  2024cites this paper
• Sleep quality and cognitive impairments in remitted patients with schizophrenia in Nigeria.

  2021cites this paper
• Risperidone Provides Better Improvement of Sleep Disturbances Than Haloperidol Therapy in Schizophrenia Patients With Cannabis-Positive Urinalysis

  2018cites this paper
• The effects of second generation antipsychotic drugs on sleep variables in healthy subjects and patients with schizophrenia.

  2017cites this paper
• Chapter 139 – Schizophrenia

  2017cites this paper
• Drugs That Disturb Sleep and Wakefulness

  2017cites this paper
• Personal and social functioning and satisfaction with life in schizophrenia outpatients with and without sleep disturbances

  2016cites this paper
• Adverse Effects of Psychotropic Medications on Sleep.

  2016cites this paper
• The effect of second-generation antipsychotic drugs on sleep parameters in patients with unipolar or bipolar disorder.

  2016cites this paper
• Dopamine and Sleep

  2016cites this paper
• Adverse Effects of Psychotropic Medications on Sleep.

  2016cites this paper
• Sleep in Schizophrenia Patients and the Effects of Second Generation Antipsychotic Drugs

  2016cites this paper
• Sleep EEG and Spindle Characteristics After Combination Treatment With Clozapine in Drug-Resistant Schizophrenia: A Pilot Study

  2015cites this paper
• Olanzapine and clozapine differently affect sleep in patients with schizophrenia: results from a double-blind, polysomnographic study and review of the literature.

  2014cites this paper
• Do sleep abnormalities and misaligned sleep/circadian rhythm patterns represent early clinical characteristics for developing psychosis in high risk populations?

  2013cites this paper
• Sömn och sömnvanor hos personer med schizofreni

  2013cites this paper
• Poor sleep as a potential causal factor in aggression and violence.

  2012cites this paper
• Chapter 57 – Schizophrenia and Its Associated Sleep Disorders

  2012cites this paper
• The Role of 5-HT2A/2C Receptors in Sleep and Waking

  2011cites this paper
• Chapter 131 – Schizophrenia

  2011cites this paper
• Alcohol, toxins, and medications as a cause of sleep dysfunction.

  2011cites this paper
• Chapter 46 – Drugs That Disturb Sleep and Wakefulness

  2011cites this paper
• Sleep and psychiatric diseases.

  2011cites this paper
• Le sommeil des personnes atteintes de schizophrénie : résultats d'études par questionnaire, polysomnographie et analyse spectrale de l'EEG en sommeil paradoxal

  2010cites this paper
• Sleep habits in middle-aged, non-hospitalized men and women with schizophrenia: a comparison with healthy controls.

  2010cites this paper
• Schlafstörungen bei schizophrenen Erkrankungen

  2010cites this paper
• Correlation of attention deficit, rapid eye movement latency and slow wave sleep in schizophrenia patients

  2009cites this paper
• GABAB Receptors, Schizophrenia and Sleep Dysfunction

  2009cites this paper
• Polysomnographic Features of Medical and Psychiatric Disorders and Their Treatments

  2009cites this paper
• Polysomnographic of Medical and Psychiatric Disorders and Their Treatments

  2009cites this paper
• Einfluß von Olanzapin auf den Schlaf und das deklarative Gedächtnis bei Patienten mit Schizophrenie

  2009cites this paper
• Sleep in Schizophrenia

  2008cites this paper
• Sleep Disturbances in Patients with Schizophrenia

  2008cites this paper
• Sommeil et schizophrénie : une revue des données expérimentales

  2008cites this paper
• The effect of typical and atypical antipsychotic drugs on sleep of schizophrenic patients

  2008cites this paper
• Sleep and Quality of Life in Schizophrenia

  2008cites this paper
• Paradoxical NREMS distribution in "pure" chronic fatigue patients a comparison with sleep apnea-hypopnea patients and healthy control subjects

  2007cites this paper
• Sleep in schizophrenia: impairments, correlates, and treatment.

  2006cites this paper
• The Sleep Problems Inventory: a measure for the assessment of sleep problems in adults with intellectual disabilities

  2006cites this paper
• Sleep and Antipsychotic Drugs in Schizophrenia Patients

  2006cites this paper
• Quality of sleep in patients with schizophrenia is associated with quality of life and coping

  2005cites this paper
• Chapter 40 – Drugs That Disturb Sleep and Wakefulness

  2005cites this paper
• Chapter 113 – Schizophrenia

  2005cites this paper
• Improved sleep continuity and increased slow wave sleep and REM latency during ziprasidone treatment: a randomized, controlled, crossover trial of 12 healthy male subjects.

  2005cites this paper
• Subchronic effects of olanzapine on sleep EEG in schizophrenic patients with predominantly negative symptoms.

  2004cites this paper
• Sleep in schizophrenia patients and the effects of antipsychotic drugs.

  2004cites this paper
• Effects of changing from typical to atypical antipsychotic drugs on subjective sleep quality in patients with schizophrenia in a Japanese population.

  2004cites this paper
• Subchronic Effects of Olanzapine on Sleep EEG in Schizophrenic Patients with Predominantly Negative Symptoms

  2004cites this paper
• Clozapine Alters Sleep-Wake Behavior in Rats

  2004cites this paper
• Sleep-promoting properties of quetiapine in healthy subjects

  2004cites this paper
• Effects of clozapine on sleep in bipolar and schizoaffective disorders.

  2004cites this paper
• Sleep quality in schizophrenia and the effects of atypical antipsychotic medication

  2004cites this paper
• Genetic dissection of drug effects in clinical practice: CLOCK gene and clozapine-induced diurnal sleepiness.

  2004cites this paper
• Sleep in untreated patients with schizophrenia: a meta-analysis.

  2004cites this paper
• Insomnias associated with psychiatric disorders

  2003cites this paper
• 102-107 S.K.norofizyoloji.qxd

  2003cites this paper
• Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects

  2003cites this paper
• REM sleep and prolactin in patients with non-affective psychoses.

  2002cites this paper
• The key-lock principle in the diagnosis and treatment of nonorganic insomnia related to psychiatric disorders: sleep laboratory investigations.

  2002cites this paper
• CASE STUDY OF CIRCADIAN RHYTHM SLEEP DISORDER FOLLOWING HALOPERIDOL TREATMENT: REVERSAL BY RISPERIDONE AND MELATONIN

  2002cites this paper
• Zur klinischen Relevanz der Wirkung von Clozapin auf die Freisetzung von Zytokinen und löslichen Zytokinrezeptoren

  2001cites this paper
• [On the clinical relevance of clozapine-triggered release of cytokines and soluble cytokine-receptors].

  2001cites this paper
• Effects of clozapine on sleep measures and sleep-associated changes in growth hormone and cortisol in patients with schizophrenia.

  2001cites this paper
• The Antipsychotic Effects of Sigma Drugs

  2000cites this paper
• Effects of antipsychotic drugs on cytokine networks.

  2000cites this paper
• Characterization of the sigma ligand panamesine, a potential antipsychotic, by immune response in patients with schizophrenia and by sleep-EEG changes in normal controls

  1999cites this paper
• Effects of typical antipsychotic drugs and risperidone on the quality of sleep in patients with schizophrenia: a pilot study.

  1999cites this paper
• Effects of granulocyte colony-stimulating factor on night sleep in humans.

  1999cites this paper
• AREGU Apr. 45/4

  1999cites this paper
• PSICOPATOLOGÍA Y SUEÑO. I. ESQUIZOFRENIA

  1998cites this paper
• Effects of antipsychotic treatment on polysomnographic measures in schizophrenia: a replication and extension.

  1998cites this paper
• Open clinical trial on the sigma ligand panamesine in patients with schizophrenia

  1997cites this paper